Enzyme-Infused Biomaterials: How Immobilized Papain, Chitosan and Graphene Hybrids Are Rewriting Wound Care and Cosmetic Masks

Table of Contents

1. Key Highlights
2. Introduction
3. Why papain? Enzymatic profile and therapeutic potential
4. Choosing supports: chitosan, graphene oxides, alginates and composites
5. Immobilization strategies: balancing activity and stability
6. Controlling release: kinetics, swelling and mechanism
7. Multipurpose enhancement: antimicrobial, antioxidant, and mechanical functions
8. Application cases: wound dresses, hypertrophic scars, and cosmetic masks
9. Manufacturing and scalability: from lab bench to clinic
10. Safety, skin physiology and risk mitigation
11. Research gaps and hurdles to clinical adoption
12. Emerging directions: sustainability, smart dressings and multifunctional textiles
13. Concrete examples from recent experimental work
14. Translational pathway: what developers must demonstrate
15. FAQ

Key Highlights

• Immobilizing papain on biopolymers such as chitosan and graphene-based supports stabilizes enzymatic activity, enables controlled release, and creates multifunctional wound dressings and facial-masking systems with antibacterial and antioxidant properties.
• Composite strategies—combining chitosan, reduced graphene oxide, ZnO, curcumin, and electrospun nanofibers—improve mechanical strength, porosity, and bioactivity, addressing chronic-wound challenges while offering scalable manufacturing routes.
• Remaining hurdles include dose control to avoid skin irritation, long-term safety of nanoscale additives, and regulatory alignment between cosmetic and medical device pathways; research trends point to circular sourcing and smart, sensor-integrated dressings.

Introduction

Proteolytic enzymes have a long history in medicine and cosmetics. Papain, a cysteine protease extracted from papaya latex, exemplifies the class: it digests necrotic tissue, shows gelatinolytic and antioxidant activity, and can accelerate tissue remodeling when applied appropriately. Historically, papain and similar enzymes were used in topical debriding agents and early cosmetic exfoliants. Recent advances in materials science have given these enzymes a second life by fastening them to engineered polymer matrices and nanomaterials. The result is not a modest tweak but a new category of multifunctional biomaterials that blend controlled biocatalysis with mechanical, antimicrobial, and antioxidant performance.

Researchers now embed papain within chitosan membranes, graphene oxide scaffolds, alginate matrices, electrospun nanofibers and other supports to address two persistent problems: enzyme instability under physiological or manufacturing conditions, and the need to deliver biological activity at the wound or skin surface without damaging healthy tissue. Immobilization transforms papain from a labile reagent into a component of engineered dressings and high-performance facial masks whose properties can be tuned—release rate, adhesion, porosity, and antimicrobial efficacy—by selecting polymers, cross-linkers and nanofillers. The following sections synthesize the latest experimental strategies, mechanistic understanding of release and activity, clinical and cosmetic applications, and the technical and regulatory challenges that remain.

Why papain? Enzymatic profile and therapeutic potential

Papain is a broad-specificity protease notable for several attributes that make it attractive for topical applications.

• Catalytic versatility: Papain cleaves peptide bonds adjacent to various amino acids and works on denatured extracellular matrix proteins and necrotic tissue. This makes it effective as a debriding agent in wound care formulations and for reducing the thickness of hypertrophic scars when delivered in a controlled manner.
• Antioxidant and anti-inflammatory roles: Beyond proteolysis, papain exhibits antioxidant activity and can moderate inflammatory signaling in tissue models. Enzymatic removal of denatured protein and debris reduces the substrate for biofilms and inflammatory mediators.
• Biocompatibility and sourcing: Papain can be isolated from Carica papaya latex in large quantities at relatively low cost. Compared with synthetic proteases, its plant origin and well-characterized activity profile support translational development.

Limitations of free papain include loss of activity at extremes of pH and temperature, rapid diffusion away from the application site, and potential irritation if overapplied. Immobilization onto solid supports reduces these risks by stabilizing the enzyme, enabling controlled release, and permitting reuse in bioreactors or extended topical function in dressings.

Choosing supports: chitosan, graphene oxides, alginates and composites

Selecting a carrier influences enzyme stability, exposure to substrates, and the physiological response. Several classes of materials have emerged repeatedly in recent studies.

Chitosan

• Rationale: A deacetylated derivative of chitin, chitosan is biodegradable, mucoadhesive, mildly antimicrobial, and promotes hemostasis. Its cationic nature facilitates interaction with negatively charged cell membranes and with enzymes.
• Advantages for papain: Chitosan can immobilize enzymes via ionic interactions, covalent cross-linking, or entrapment. It enhances wound healing through intrinsic bioactivity and supports gels and membranes for dressing manufacture.
• Examples: Papain-immobilized chitosan membranes have shown promise as wound dressings, maintaining enzyme activity while providing a moist environment conducive to healing.

Graphene oxide (GO) and reduced graphene oxide (rGO)

• Rationale: GO and rGO offer extremely high surface area, tunable surface chemistry and mechanical reinforcement to polymer matrices.
• Effects on enzymes: GO can modulate enzyme activity in complex ways; some studies show activity enhancement through favorable adsorption and orientation, while reduction to rGO changes surface charge and hydrophobicity, altering protein interactions.
• Composite roles: GO/rGO combined with chitosan yields aerogels and nanofibrous scaffolds with improved tensile strength and electrical conductivity—properties useful for mechanically demanding dressings and for potential sensor-enabled textiles.

Alginate, cellulose nanocrystals and polydopamine-coated supports

• Alginate provides gentle entrapment of enzymes in hydrogels that swell to release cargo. It suits moist wound environments.
• Cellulose nanocrystals, sometimes coated with polydopamine, act as stabilizing platforms that improve papain tolerance to pH and temperature extremes.
• Ionic gelation and layer-by-layer deposition permit fabrication of membranes and microspheres for oral or topical protection of enzymes.

Composite strategy: the trend favors hybrid matrices that combine chitosan’s bioactivity with GO/rGO’s mechanical and functional properties and additional bioactives such as ZnO or curcumin for antimicrobial and antioxidant action. Integration of multiple components allows tailoring of porosity, mechanical strength and release profiles.

Immobilization strategies: balancing activity and stability

Immobilization methods determine how papain retains activity, how tightly it binds, and how it releases.

Physical adsorption

• Simple and often preserves native conformation.
• Weak binding leads to enzyme leaching and faster initial release, which can be desirable for immediate debridement but problematic for prolonged applications.

Ionic interactions and entrapment

• Ionic gelation (as with alginate or chitosan) traps papain while retaining aqueous access for substrates.
• Entrapment minimizes direct chemical modification of the enzyme but can restrict substrate diffusion and reduce apparent activity.

Covalent attachment

• Strong binding via carbodiimide chemistry, glutaraldehyde cross-linking or click-type reactions increases stability across pH and temperature ranges.
• Covalent conjugation can reduce catalytic turnover if active-site residues are modified or mobility is constrained.
• Engineering the attachment point away from the active site is critical.

Cross-linked enzyme aggregates and hybrid nanoflowers

• Cross-linked aggregates or hybrid structures (for example, papain/Zn3(PO4)2 nanoflowers) increase activity per mass and protect the enzyme microenvironment.
• These constructs exhibit enhanced catalytic stability and can be functionally embedded within membranes.

Surface coating and biomimetic layers

• Polymer coatings (e.g., polydopamine on cellulose nanocrystals) protect papain from denaturation while permitting controlled substrate access.
• Coatings can tune surface charge and hydrophobicity to reduce nonspecific protein adsorption and control release.

Magnetic nanoparticle and graphene-based immobilization

• Immobilizing papain on magnetic nanoparticles or graphene oxide enables enzyme recovery and reuse in bioprocessing, and can anchor enzymes in dressings where magnetic manipulation or orientational control is needed.
• The nature of the nanoparticle surface and crosslinker influences aggregation and the accessible active-site conformation.

Trade-offs and design principles

• Maximize enzyme stability with minimal loss of catalytic efficiency.
• Position covalent linkages or adsorption sites to avoid obstructing the active site.
• Design pore size and swelling characteristics to maintain nutrient/waste exchange while limiting uncontrolled diffusion of papain into healthy tissue.

Controlling release: kinetics, swelling and mechanism

Delivering papain at therapeutic levels over a defined timeframe requires understanding the physics of release from polymer matrices. Two classical models arise frequently in the literature.

Higuchi model

• Describes release as a diffusion-controlled process from a homogeneous matrix, proportional to the square root of time.
• Useful when drug/enzyme is dispersed in a solid matrix from which solvent penetration controls release.

Korsmeyer–Peppas model

• Captures cases where release combines diffusion and polymer relaxation (swelling) mechanisms.
• The release exponent (n) indicates whether diffusion, swelling, or anomalous transport dominates.

Practical determinants of release profile

• Matrix porosity and pore size govern diffusion pathways. Electrospun nanofibers typically yield higher porosity and larger surface area, accelerating release unless crosslinked.
• Hydrophilicity and swelling behavior of the polymer affect solvent uptake and the rate at which enzyme can migrate to the surface.
• Degree of immobilization: covalently bound enzymes show minimal bulk release and act more like catalysts anchored to the dressing surface, whereas physically entrapped enzymes show measurable elution.
• Addition of fillers (GO, ZnO, curcumin) can create tortuous pathways for diffusion, slowing release and adding secondary functionalities such as antibacterial action.

Design examples

• Nanofiber patches engineered with chitosan-PCL blends and curcumin-loaded nanoparticles show staged release: an initial burst to reduce bioburden followed by sustained antioxidant delivery for several days.
• Hydrogels with high-acyl gellan gum or similar polysaccharides demonstrate slow, swelling-controlled release suited to chronic wound environments that require prolonged enzyme activity.

Multipurpose enhancement: antimicrobial, antioxidant, and mechanical functions

Wound infections and chronic inflammation undermine healing. Hybrid biomaterials pair papain with additives that address these threats.

Antibacterial agents

• Chitosan demonstrates intrinsic broad-spectrum activity and can disrupt bacterial membranes.
• Zinc oxide (ZnO) nanoparticles exhibit antimicrobial and antibiofilm properties, particularly when integrated into electrospun fibers or chitosan composites.
• Reduced graphene oxide and rGO-based composites show antibacterial effects that depend on particle size, surface chemistry and preparation method; green syntheses yield materials with added antioxidant properties.

Antioxidants and anti-inflammatory actives

• Curcumin is a widely studied natural antioxidant; when loaded into nanoparticle carriers and co-delivered with papain, it reduces oxidative stress and inflammation in the wound bed.
• Collagen peptides and gelatin-derived products support tissue remodeling and can be co-encapsulated to provide structural cues for cell migration.

Mechanical reinforcement and porosity management

• GO and rGO increase mechanical resilience and tensile strength in aerogels and membranes, improving handling and reducing fracture risk in dressings.
• Electrospun nanofibers provide a tunable architecture where fiber diameter and alignment control cell infiltration and vascularization.
• Properly designed porosity permits vascular in-growth while maintaining moisture balance and preventing excessive protease diffusion.

Synergy in multifunctional systems

• A composite dressing that immobilizes papain on chitosan and integrates ZnO and curcumin can simultaneously debride necrotic tissue, reduce local infection risk and mitigate oxidative stress—each function reinforcing the others to accelerate healing.
• Examples in preclinical models demonstrate improved angiogenesis, faster closure and reduced bacterial colonization with such multifunctional scaffolds.

Application cases: wound dresses, hypertrophic scars, and cosmetic masks

Clinical need and consumer demand drive distinct application niches for papain-enabled materials. The same properties that benefit wound care—controlled activity, adhesion, antimicrobial protection—translate into advanced cosmetic formats.

Wound dressings and ulcer care

• Chronic wounds such as diabetic ulcers and pressure sores require debridement, infection control and a moist healing environment. Papain-embedded chitosan membranes and chitosan-alginate patches fulfill these needs by maintaining activity at the wound interface while keeping the wound bed hydrated.
• Studies using papain immobilized on alginate membranes and on chitosan-coated magnetic nanoparticles show favorable in vitro and in vivo wound-healing metrics: increased collagen deposition, improved epithelialization, and decreased bacterial counts.

Hypertrophic scars and remodeling

• Papain delivered in elastic liposomes or enzyme-loaded membranes targets excessive collagen accumulation in hypertrophic scars. Elastic carriers permit skin penetration without compromising the active-site integrity of the enzyme.
• Applications in animal models exhibit scar-thinning effects when proteolytic action is carefully dosed to remove surplus extracellular matrix without injuring viable dermis.

Cosmetic facial masks and anti-aging patches

• The cosmetic industry increasingly adopts biomaterials technologies from wound care. Biocompatible anti-aging masks incorporating antioxidant agents such as curcumin within natural rubber or polymer matrices combine oxidative stress reduction with gentle exfoliation mediated by immobilized proteases.
• Fabrication methods include hydrogel patches, electrospun nonwovens, and sheet masks impregnated with enzyme-stabilizing nanoparticles. These designs seek to control proteolytic activity to avoid irritation while providing visible exfoliation and skin renewal.

Textiles and wearable patches

• Cotton-like antibacterial scaffolds and fiber-reinforced chitosan constructs enable textile-based dressings that conform to body contours. Functional textiles can now incorporate enzyme reservoirs and even nascent sensor elements for monitoring wound conditions.

Translational examples

• Preclinical reports of reduced graphene oxide-isabgol dressings in diabetic rat models show enhanced vascularization and faster healing relative to controls.
• Papain–Zn hybrid nanoflowers and papain-loaded chitosan membranes show increased catalytic stability and wound-repair outcomes in laboratory studies.

Manufacturing and scalability: from lab bench to clinic

Developing enzyme-loaded dressings and masks that can be manufactured at scale requires integration of formulation science, textile engineering and quality control.

Fabrication techniques

• Electrospinning and electrospraying produce nanofibrous mats at pilot and industrial scales, enabling consistent control of fiber diameter, porosity and loading of nanoparticles or enzyme-containing microspheres.
• Lyophilization (freeze-drying) creates dry, rehydratable matrices suitable for long-shelf-life products, including orally disintegrating delivery forms or lyophilized masks.
• Layer-by-layer deposition and coating methods permit precise localization of enzyme layers on substrates, which is useful when designers want enzymes close to the wound interface while protective polymers reduce systemic exposure.

Process control and characterization

• Key quality attributes include enzyme activity per unit area, release kinetics, mechanical integrity, pore architecture and sterility.
• Stability assays must assess residual activity after sterilization steps—gamma irradiation, ethylene oxide or other methods—and during storage under expected conditions.
• Aggregation of nanoparticles and enzymes must be monitored; particle size affects not only activity but safety and interfacial mechanics.

Supply chain and sourcing

• Biopolymers derived from waste biomass—cellulose, chitin—offer sustainable sources for chitosan and related materials.
• Insect-derived chitin (Hermetia illucens) and other circular-economy feedstocks are under active investigation to reduce reliance on marine or crustacean sources.
• Consistent papain supply requires standardized extraction and purification to ensure reproducible activity and low allergen content.

Regulatory and commercialization considerations

• Products intended for wound care typically classify as medical devices, drug-device combinations or topical drugs, depending on claims and mechanism; each regulatory path demands different evidence for safety and efficacy.
• Cosmetic applications follow different regulatory frameworks focused on safety and labeling rather than clinical efficacy; nonetheless, enzyme-containing cosmetics must demonstrate low irritation and acceptable preservative systems.
• Scaling antimicrobial and nanoparticle components invites additional regulatory scrutiny regarding nanoparticle identity, impurities, and long-term safety.

Safety, skin physiology and risk mitigation

Applying an active protease to skin or wound tissue requires careful attention to physiological parameters and patient safety.

Skin pH and enzyme performance

• Healthy skin surface pH averages near 5.5 and can influence papain activity. Formulations must either buffer enzyme microenvironments or immobilize enzymes such that activity occurs primarily on necrotic protein substrates rather than healthy tissue.

Proteolytic risk and dosing

• Overexposure to proteases risks digesting healthy extracellular matrix proteins and impairing healing. Immobilization reduces this risk by limiting diffusion; covalent or strong adsorption strategies keep enzyme localized, and staged-release systems prevent excessive short-term dosing.

Allergenicity and irritation

• Papain can act as an allergen in sensitized individuals. Clinical formulations require purification to remove allergenic contaminants and clinical testing to measure irritation indices. Patch testing and conservative clinical trials are standard mitigations.

Nanomaterial safety

• Graphene-based materials, ZnO nanoparticles and other nanoscale additives raise biocompatibility concerns. Particle size, surface coating, and synthesis by-products influence cytotoxicity and inflammatory potential.
• Green synthesis and rigorous characterization of particle size distribution, surface charge and residual reagents reduce safety risks and improve regulatory acceptability.

Sterility and microbial control

• Dressings intended for open wounds must preserve sterility during storage and application. Embedding antimicrobials like chitosan or ZnO adds defense against contamination but cannot substitute for aseptic manufacturing and packaging controls in medical-grade products.

Research gaps and hurdles to clinical adoption

Despite promising laboratory results, several unresolved questions limit immediate broad clinical use.

Standardization of immobilization protocols

• Diverse immobilization chemistries and supports yield incomparable data. Standard methods to quantify immobilized enzyme loading, retained activity and release under physiologically relevant conditions would accelerate comparison across studies.

Long-term fate of nanomaterials

• The biodistribution, biodegradation and possible accumulation of graphene derivatives and metal oxide nanoparticles require comprehensive in vivo safety studies. Chronic-exposure scenarios and systemic translocation are poorly understood.

Dose-response and tissue specificity

• Optimal dosing windows for papain in different wound types remain to be fully established. Controlled clinical trials that compare immobilized versus free enzyme formulations—and versus standard debridement agents—are scarce.

Manufacturing under regulatory frameworks

• Manufacturing challenges include sterilization compatibility with enzyme integrity, batch-to-batch reproducibility of composite materials, and scale-up of nanomaterial integration with acceptable quality control metrics.

Integration with sensing technologies

• Combining therapeutic dressings with sensors that monitor pH, oxygenation or breath biomarkers demands integration of electronics and biocompatible substrates. Chemiresistive breathomic nanosensors and graphene-based sensing chips provide a possible route, but robust, clinical-grade implementations are still in development.

Emerging directions: sustainability, smart dressings and multifunctional textiles

Several trends are shaping near-term research and commercial opportunities.

Circular materials and alternative chitin sources

• Deriving chitin and chitosan from insect biomass represents a scalable, lower-impact supply route and aligns with circular-economy goals. Processing these feedstocks into consistent-grade biopolymers is central to adoption.

Smart dressings with monitoring capabilities

• Embedding sensors within dressings can provide real-time data on infection (biomarkers, pH), moisture balance and oxygenation. Chemiresistive sensors on flexible graphene-based substrates could signal the need for dressing change or detect early infection.

Multifunctional textiles

• Combining flame retardancy, antibacterial properties and enzyme reservoirs in cotton or linen fabrics may find niche applications in high-risk care environments or specialized cosmetics. Dual-function finishing chemistries and polymer modifications enable such combinations without compromising wearer comfort.

Controlled, hypoxia-activated approaches

• Concepts borrowed from long-acting prodrug design—hypoxia-activated or environment-responsive release—could yield dressings that turn on proteolysis only in the presence of necrotic tissue or infection-related microenvironments. This minimizes collateral damage to healthy tissue.

Sensor-guided, staged release

• Algorithms that interpret sensor data (pH, enzymatic activity, gas biomarkers) could trigger timed release of proteases, antimicrobials or anti-inflammatories from layered matrices, creating closed-loop therapeutic systems.

Concrete examples from recent experimental work

Several translational studies illustrate the potential and pitfalls of papain-immobilized composites.

Papain in chitosan membranes

• Researchers have immobilized papain on chitosan membranes and documented sustained proteolytic activity along with improvements in wound closure metrics in preclinical models. The chitosan matrix contributed antimicrobial action and supported cell viability in adjacent tissue.

Papain–Zn nanoflowers and hybrid supports

• Nanoflower architectures that incorporate papain within inorganic matrices increase surface area and catalytic turnover. Such constructs demonstrate enhanced stability at variable pH and retain activity when incorporated into dressings.

Electrospun nanofibers loaded with curcumin and nanoparticles

• Electrospun PCL/chitosan scaffolds electrosprayed with curcumin-loaded chitosan nanoparticles offer an initial burst of antimicrobial/antioxidant action followed by sustained structural support. When papain is incorporated, these constructs combine debridement with oxidative stress mitigation.

Reduced graphene oxide-isabgol composite dressings

• rGO combined with natural polysaccharides has produced dressings that promote vascularization and accelerate healing in diabetic models, highlighting the value of mechanical and biochemical synergy.

Anti-aging face masks with curcumin and rubber matrices

• Anti-aging masks that immobilize antioxidant curcumin within biocompatible rubber or polymer matrices show promising antioxidant properties and consumer-appealing textures. When combined with controlled, low-level enzymatic exfoliation, such masks improve skin texture while minimizing irritation.

Translational pathway: what developers must demonstrate

For a papain-immobilized dressing or cosmetic mask to reach market, developers should provide:

• Comprehensive characterization: enzyme loading, release kinetics, mechanical properties, porosity, nanoparticle characterization and sterility assurance.
• Stability and shelf-life data under proposed storage conditions, including post-sterilization activity.
• Preclinical safety: cytotoxicity, local irritation, allergenicity screening, and in vivo wound-healing studies in relevant models.
• Comparative efficacy studies that position the product relative to existing debridement agents, antimicrobial dressings and cosmetic exfoliants.
• Manufacturing validation for consistent production, including control of nanoparticle size, surface chemistry and polymer molecular weight distributions.
• Regulatory strategy: classification as a medical device, drug-device combination or cosmetic; clinical trial plans aligned with regulatory requirements.

FAQ

Q: How does immobilizing papain make it safer or more effective than applying free papain? A: Immobilization stabilizes the enzyme against pH and temperature extremes, localizes activity to the dressing surface to reduce the risk of proteolysis of healthy tissue, and enables controlled release that avoids the high initial doses associated with free enzyme application. Covalent or strong adsorption reduces enzyme leaching, which is valuable for prolonged wound care.

Q: Can enzyme-containing dressings be sterilized without losing activity? A: Sterilization compatibility depends on the method. Heat and some irradiation methods can denature papain. Ethylene oxide sterilization, aseptic manufacturing, or incorporation of enzyme after terminal sterilization are common strategies. Each approach requires validation: measure residual activity and ensure absence of harmful residues.

Q: Are graphene-based additives safe in contact with skin and wounds? A: Safety depends on particle size, surface chemistry, dose and manufacturing purity. Well-characterized, coated or functionalized graphene derivatives with controlled size distributions have shown acceptable biocompatibility in many preclinical studies. Nonetheless, comprehensive safety evaluations—cytotoxicity, inflammatory response, biodistribution—are necessary for clinical use.

Q: Could papain cause allergic reactions? A: Papain is a known sensitizer for some individuals. Purification to remove allergenic contaminants reduces that risk, and clinical testing (e.g., patch tests) should be conducted. Risk-benefit analysis and clear labeling are essential for both therapeutic and cosmetic products.

Q: How long will enzyme activity persist in a dressing? A: Persistence depends on immobilization method, matrix properties and wound environment. Covalently bound papain can remain active for days to weeks depending on proteolytic turnover and denaturation rates. Entrapped enzymes typically show an initial burst followed by declining release over hours to days. Empirical testing in simulated wound conditions yields the best estimate.

Q: Are there examples of commercial products using immobilized proteases? A: Historically, some topical enzymatic debriding agents and cosmetic formulations have employed proteases. The newer generation of immobilized enzyme dressings and multifunctional composites is largely at the preclinical or early translational stage, with prototypes demonstrating promising wound-healing outcomes and cosmetic benefits in laboratory studies.

Q: What regulatory path applies to enzyme-containing facial masks versus wound dressings? A: Facial masks that claim cosmetic benefits are regulated under cosmetic frameworks focusing on safety and labeling. Wound dressings that claim therapeutic benefit are regulated as medical devices, drugs, or combination products, depending on the mechanism and claims. This distinction affects the type of data required for approval.

Q: What are the most promising near-term applications? A: Advanced dressings for chronic wounds (diabetic foot ulcers, pressure injuries) and specialized anti-scarring therapies for hypertrophic or hypertrophic scars appear immediately translational. Cosmetic facial masks that use immobilized proteases in gentle, controlled-release formats are commercially viable sooner due to lighter clinical requirements—provided safety and irritation are well demonstrated.

Q: How does the presence of other bioactives (curcumin, ZnO) change performance? A: Co-encapsulated antioxidants and antimicrobials reduce infection risk and oxidative stress and can complement proteolytic debridement. These additives often slow enzyme release by creating diffusion barriers and can strengthen matrices mechanically. However, interactions between additives and enzyme active sites must be tested to avoid activity loss.

Q: Where is research heading next? A: Integration with sensing technologies, circular sourcing of biopolymers, environmentally friendly synthesis of graphene derivatives, and environment-responsive, staged-release systems represent the most active directions. Researchers are also focusing on standardized methodologies for immobilization and cross-disciplinary testing to accelerate clinical translation.

— End —